Abstract: Retrospective Outcomes of Psychedelic Therapy Among US Special Operations Forces Veterans (Society for Social Work and Research 27th Annual Conference - Social Work Science and Complex Problems: Battling Inequities + Building Solutions)
Search | Browse by Day | Presenter Index
All in-person and virtual presentations are in Mountain Standard Time Zone (MST).

SSWR 2023 Poster Gallery: as a registered in-person and virtual attendee, you have access to the virtual Poster Gallery which includes only the posters that elected to present virtually. The rest of the posters are presented in-person in the Poster/Exhibit Hall located in Phoenix A/B, 3rd floor. The access to the Poster Gallery will be available via the virtual conference platform the week of January 9. You will receive an email with instructions how to access the virtual conference platform.

Retrospective Outcomes of Psychedelic Therapy Among US Special Operations Forces Veterans

Schedule:
Friday, January 13, 2023
Desert Sky, 3rd Level (Sheraton Phoenix Downtown)
* noted as presenting author
Nathan Sepeda, BS, Research Assistant, Ohio State University, Columbus, OH
Special Operations Forces Veterans completed an anonymous survey in which they retrospectively reported on mental health, cognitive functioning, and alcohol use in the 30 days before and 30 days after receiving psychedelic treatment. A total of 65 SOFV completed treatment, and 51 (78%) completed the survey (mean age = 40; male = 96%; married = 55%; Caucasian/White = 92%). Results indicated significant and very large reductions in suicidal ideation (p < .001; d = -1.9), cognitive impairment (p < .001; d = -2.8), alcohol use (p < .001; d = -2.4), and symptoms of posttraumatic stress disorder (PTSD) (p < .001; d = -3.6), depression (p < .001; d = -3.7), and anxiety (p < .001; d = -3.1) from before-to-after treatment. Results also showed a significant and large increase in psychological flexibility (p < .001; d = 2.9), which was strongly associated with reductions in alcohol use and PTSD symptoms (rs range .38-.90; ps < .05). Additionally, most SOFV (84%) rated the psychedelic experiences among the top five personally meaningful experiences of their lives. Psychedelic treatment with ibogaine and 5-MeO-DMT may hold promise for treating the sequela of problems associated with repeated trauma exposure among SOFV.
Back to: Psychedelic Therapy for United States Military Veterans with a History of Combat and Deployment Trauma
<< Previous Abstract | Next Abstract >>